TY - CHAP
T1 - From chronic stress and anxiety to neurodegeneration
T2 - Focus on neuromodulation of the axon initial segment
AU - Radulovic, Jelena
AU - Ivkovic, Sanja
AU - Adzic, Miroslav
N1 - Funding Information:
This work was supported by NIMH grants MH108837 and MH078064 to J.R., and by the Ministry of Education, Science and Technological Development of the Republic of Serbia to S.I. and M.A. Special thanks to Viktoriya Grayson and Mariah Meyer for their help with organizing the bibliography.
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/1
Y1 - 2022/1
N2 - To adapt to the sustained demands of chronic stress, discrete brain circuits undergo structural and functional changes often resulting in anxiety disorders. In some individuals, anxiety disorders precede the development of motor symptoms of Parkinson's disease (PD) caused by degeneration of neurons in the substantia nigra (SN). Here, we present a circuit framework for probing a causal link between chronic stress, anxiety, and PD, which postulates a central role of abnormal neuromodulation of the SN's axon initial segment by brainstem inputs. It is grounded in findings demonstrating that the earliest PD pathologies occur in the stress-responsive, emotion regulation network of the brainstem, which provides the SN with dense aminergic and cholinergic innervation. SN's axon initial segment (AIS) has unique features that support the sustained and bidirectional propagation of activity in response to synaptic inputs. It is therefore, especially sensitive to circuit-mediated stress-induced imbalance of neuromodulation, and thus a plausible initiating site of neurodegeneration. This could explain why, although secondary to pathophysiologies in other brainstem nuclei, SN degeneration is the most extensive. Consequently, the cardinal symptom of PD, severe motor deficits, arise from degeneration of the nigrostriatal pathway rather than other brainstem nuclei. Understanding when and how circuit dysfunctions underlying anxiety can progress to neurodegeneration, raises the prospect of timed interventions for reversing, or at least impeding, the early pathophysiologies that lead to PD and possibly other neurodegenerative disorders.
AB - To adapt to the sustained demands of chronic stress, discrete brain circuits undergo structural and functional changes often resulting in anxiety disorders. In some individuals, anxiety disorders precede the development of motor symptoms of Parkinson's disease (PD) caused by degeneration of neurons in the substantia nigra (SN). Here, we present a circuit framework for probing a causal link between chronic stress, anxiety, and PD, which postulates a central role of abnormal neuromodulation of the SN's axon initial segment by brainstem inputs. It is grounded in findings demonstrating that the earliest PD pathologies occur in the stress-responsive, emotion regulation network of the brainstem, which provides the SN with dense aminergic and cholinergic innervation. SN's axon initial segment (AIS) has unique features that support the sustained and bidirectional propagation of activity in response to synaptic inputs. It is therefore, especially sensitive to circuit-mediated stress-induced imbalance of neuromodulation, and thus a plausible initiating site of neurodegeneration. This could explain why, although secondary to pathophysiologies in other brainstem nuclei, SN degeneration is the most extensive. Consequently, the cardinal symptom of PD, severe motor deficits, arise from degeneration of the nigrostriatal pathway rather than other brainstem nuclei. Understanding when and how circuit dysfunctions underlying anxiety can progress to neurodegeneration, raises the prospect of timed interventions for reversing, or at least impeding, the early pathophysiologies that lead to PD and possibly other neurodegenerative disorders.
KW - Anxiety
KW - Axon initial segment
KW - Neurodegeneration
KW - Neuromodulation
KW - Parkinson's disease
UR - http://www.scopus.com/inward/record.url?scp=85122660154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122660154&partnerID=8YFLogxK
U2 - 10.1016/B978-0-12-819410-2.00025-4
DO - 10.1016/B978-0-12-819410-2.00025-4
M3 - Chapter
C2 - 35034756
AN - SCOPUS:85122660154
T3 - Handbook of Clinical Neurology
SP - 481
EP - 495
BT - Handbook of Clinical Neurology
PB - Elsevier B.V.
ER -